Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Meghan McCarty Carino

👤 Speaker
292 total appearances

Appearances Over Time

Podcast Appearances

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

We'll be right back.

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

You are listening to Marketplace Tech.

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

I'm Megan McCarty Carino.

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

We're back with writer and UC Berkeley lecturer Britt Young.

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

So what do you think would need to change in order for 3D printing to actually deliver on the promise of cheaper prosthetics?

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

The American healthcare system obviously has its own idiosyncrasies, but I'm curious if sort of on a global level you think that 3D printing will ever deliver on, you know, the promise of reducing the cost of these devices.

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

So bottom line, do you think that this technology will successfully bring costs down at some point?

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

That was writer Britt Young.

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

We've linked to her article about the complicated economics of 3D printed prosthetics at our website, marketplacetech.org.

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

Daniel Shin produced this episode.

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

I'm Megan McCarty Carino, and that's Marketplace Tech.

Marketplace All-in-One
3D printing was supposed to disrupt prosthetic costs. It hasn’t.

This is APM.

← Previous Page 15 of 15 Next →